1. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft‐versus‐host disease after marrow transplantation from unrelated donors;Nash RA;Blood,2000
2. A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
3. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft‐versus‐host disease prophylaxis after HLA‐identical sibling bone marrow transplantation;Ratanatharathorn V;Blood,1998
4. Cytochrome P‐450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat;Sattler M;Drug Metab Dispos,1992
5. Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus